Searching News Database: nasolabial folds
HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
HSMN NewsFeed - 28 Mar 2019
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
HSMN NewsFeed - 14 Jun 2016
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
HSMN NewsFeed - 14 May 2013
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
HSMN NewsFeed - 23 Feb 2010
Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
HSMN NewsFeed - 2 Feb 2010
Two Studies Find Artefill(R) to Be a Long-Term Treatment Option for Facial Lipoatrophy
Two Studies Find Artefill(R) to Be a Long-Term Treatment Option for Facial Lipoatrophy
HSMN NewsFeed - 10 Feb 2009
Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
HSMN NewsFeed - 14 Apr 2008
Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch
Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch
HSMN NewsFeed - 8 Jan 2008
Artes Medical Names Dr. John F. Kay as Vice President, Engineering and Development
Artes Medical Names Dr. John F. Kay as Vice President, Engineering and Development
HSMN NewsFeed - 11 Dec 2007
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
HSMN NewsFeed - 26 Jun 2007
Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus
Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus
HSMN NewsFeed - 17 Apr 2007
ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
HSMN NewsFeed - 1 Feb 2007
Artes Medical Announces Landmark Five Year Study Results for ArteFill, a Non-Resorbable Dermal Filler
Artes Medical Announces Landmark Five Year Study Results for ArteFill, a Non-Resorbable Dermal Filler
HSMN NewsFeed - 28 Nov 2006
Artes Medical Names Diane S. Goostree President and Chief Executive Officer
Artes Medical Names Diane S. Goostree President and Chief Executive Officer
Additional items found! 15
Members Archive contains
15 additional stories matching:
nasolabial folds
(Password required)
nasolabial folds
(Password required)